Brooke Hinkson
Corporate Officer/Principal at MERCK & CO., INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Davis | M | 57 | 10 years | |
Chris Decker | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
David R. Bobbitt | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 7 years |
Caroline Litchfield | F | 55 | 34 years | |
Dalton Smart | M | 58 | 15 years | |
Pamela Craig | F | 67 | 9 years | |
Chirfi Guindo | M | 58 | 13 years | |
Mary Coe | F | 57 | 5 years | |
Christine Seidman | M | 71 | 4 years | |
Kathy Warden | F | 52 | 4 years | |
Stephen Mayo | M | 62 | 3 years | |
Tom Glocer | M | 63 | 17 years | |
Jennifer Zachary | F | 46 | 6 years | |
Douglas Baker | M | 65 | 2 years | |
Inge Thulin | M | 69 | 6 years | |
Patricia Russo | F | 71 | 29 years | |
Peter Wendell | M | 73 | 21 years | |
Risa Lavizzo-Mourey | M | 69 | 4 years | |
Paul Rothman | M | 66 | 9 years | |
Steven Graziano | M | - | 18 years | |
Damini Chokshi | F | - | - | |
Kelly E. W. Grez | F | - | - | |
Joyce Sensmeier | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Johanna Herrmann | F | - | - | |
Jannie Oosthuizen | M | - | 3 years | |
Sylvia A. Ayler | F | - | 3 years | |
Lisa Lin | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 2 years |
Karen Curran | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 2 years |
Andre Musto | M | - | 10 years | |
Julie Cunningham | F | - | - | |
Christina Reith | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Carol Bowden | F | - | 10 years | |
Allan Gabor | M | - | 11 years | |
Joseph Romanelli | M | 50 | 2 years | |
David Hardison | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Pamela Eisele | F | - | 15 years | |
Richard DeLuca | M | 61 | 13 years | |
Dean Li | M | 62 | 7 years | |
Anand Ganesan | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
James Matteucci | M | - | 21 years | |
Douglas J. Peddicord | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Sanat Chattopadhyay | M | - | 15 years | |
Eric Rubin | M | 65 | 6 years | |
Dominic F. Labriola | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 1 years |
Denise Williams | F | - | 15 years | |
Cristal Downing | M | 55 | 3 years | |
Peter Dannenbaum | M | - | 7 years | |
Isabelle de Zegher | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Fiona Hamilton Marshall | M | 59 | - | |
Michael Klobuchar | M | 48 | 3 years | |
Dave Williams | M | 55 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kenneth Frazier | M | 69 | 30 years | |
Rochelle Lazarus | F | 76 | 16 years | |
John Noseworthy | M | 71 | - | |
Michael Nally | M | 48 | 10 years | |
Craig Thompson | M | 71 | 10 years | |
Natarajan Sethuraman | M | 62 | 10 years | |
Teri Loxam | F | 52 | 4 years | |
David A. Evans | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 3 years |
Charles Kidder | M | 79 | 12 years | |
Wendell Weeks | M | 64 | 16 years | |
Sheila Ranganath | F | - | 5 years | |
Leslie Brun | M | 72 | 13 years | |
Christopher Galloway | M | 53 | 2 years | |
Marvin Johnson | M | 61 | 2 years | |
Lisa LeCointe-Cephas | F | 42 | 6 years | |
Daniel Pascheles | M | - | 11 years | |
Kevin Ali | M | 63 | 2 years | |
Aaron Falcione | M | 53 | - | |
Soren Christiansen | M | 68 | 19 years | |
Joseph Arena | M | 69 | 1 years | |
Vicki Goodman | M | 55 | 1 years | |
Jared Cumming | M | - | 1 years | |
Quentin Roach | M | 57 | 4 years | |
Jim Robinson | M | - | 5 years | |
Amy Klug | F | - | - | |
Arnaub Chatterjee | M | - | 5 years | |
Guy Padbury | M | - | 6 years | |
Rongqiang Liu | M | 58 | 4 years | |
Tracy Ogden | F | - | - | |
Sandy Tremps | F | - | 33 years | |
Sandra Milligan | M | 50 | 5 years | |
Willie Deese | M | 68 | 12 years | |
Adam Schechter | M | 58 | 30 years | |
Michael Rosenblatt | M | 76 | 32 years | |
Tamara Elias | M | 53 | 2 years | |
Michael Holston | M | 61 | 6 years | |
Mathai Mammen | M | 57 | 1 years | |
Joe Pedersen | M | - | 23 years | |
Jill DeSimone | F | 68 | 8 years | |
Ken Johnson | M | 61 | 1 years | |
Franklin Clyburn | M | 59 | 13 years | |
Phillip Samayoa | M | 37 | - | |
Andrew Davis | M | 38 | 1 years | |
James Scholefield | M | 62 | 1 years | |
Guy Patrick M. Eiferman | M | - | 4 years | |
Francesco Maria Lavino | M | 51 | 2 years | |
Steven Mizell | M | 64 | 8 years | |
Roger Dansey | M | 68 | 3 years | |
Jonathan Robbins | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brooke Hinkson
- Personal Network